Medical Concern: Market Prospect Of The 30 Kinds Of Raw Drugs - Bulk Drugs, Pharmaceutical, Market -

Current common name API Plant and wishing to enter the field on behalf of the plant

, the selection of suitable projects to develop is a very important thing. The development process from the field of view, choose to develop their sales agents more than one billion U.S. dollars of major new drugs bulk drugs, where is the hope and opportunity. Described below within the past few years, great development potential of new drugs bulk drugs, mainly in the cardiovascular, Cancer Related to arthritis and central nervous system in four areas is estimated that the drugs in 2008 accounted for 60% of large-scale drug sales reached 53.4 billion U.S. dollars.

Cardiovascular: 6 Potential cardiovascular drugs in a total of 6, are high blood pressure medication, including four belonging to angiotensin receptor inhibitors, including AstraZeneca (Takeda) in the candesartan (Candesartan), drug 2002 sales of 5.7 billion, in 2003 about 760 million U.S. dollars, in 2008 estimated that up to 20 million; Bristol-Myers Squibb of irbesartan? xIrbesartan?? 2002 had sales of 586 million U.S. dollars, 2003 year 730 million U.S. dollars, in 2008 estimated that 13.4 million; Bo Ingelheim and standard cell GlaxoSmithKline Contract development and sale of telmisartan (telmisartan), 2002 sales of 3.1 billion, about 450 million U.S. dollars in 2003, 2008, estimated at 20 million; three of pharmacy olmesartan (Olmesartan), 2002 sales of 0.6 billion U.S. dollars, 2003 was 1.46 million, 2008 estimated 1.324 billion U.S. dollars; AstraZeneca metoprolol (metaprolol), 2002 had sales of 900 million U.S. dollars, 10.5 in 2003 100 million U.S. dollars, in 2006 reached 1.25 billion U.S. dollars estimated in 2008 reached 570 million U.S. dollars; former Aventis Ramipril (ramipril), 2002 had sales of 8.7 U.S. dollars 100 million, approximately 960 million U.S. dollars in 2003, 2008 estimated at 890 million U.S. dollars. By 2008, total sales of these drugs, about 90 million, growth rate of 25.5%, accounting for 19% share of large-scale drug.

Cancer-related areas: 5 Potential cancer-related drugs a total of 5: Eli Lilly and gemcitabine (gemcitabine), 2002 sales of 8.75 billion dollars, about 986 million U.S. dollars in 2003, 2008, estimated at 1.62 billion U.S. dollars; Roche of trastuzumab (trastuzumab), 2002 sales of 6.5 billion, about 740 million U.S. dollars in 2003, 2008, estimated at 1.03 billion U.S. dollars; Novartis Zoledroicacid, 2002 sales of 4.9 billion, 2008 is estimated at 2.82 billion U.S. dollars; Novartis, imatinib (imatinib), 2002 sales of 6.1 billion, about 890 million U.S. dollars in 2003, 2008, estimated at 1.39 billion U.S. dollars; security into the PEG pegfilgrastim (pegfilgrastim), 2002 sales of 4.6 billion, about 1.02 billion U.S. dollars in 2003, 2008, estimated at 2.82 billion U.S. dollars. By 2008, these five kinds of drugs, total sales will reach 9 billion U.S. dollars, accounting for 17.1% share of major new drugs.

Arthritis: 3

Arthritis-related potential total of three drugs, including Abbott's adalimumab (adalimumab), 2003 sales of 2.5 billion, 2008 is estimated at 1.75 billion; Amgen's etanercept ( etanercept); Pfizer's Bextra (valdecoxib), 2002 sales of 4.7 billion, 990 million U.S. dollars in 2003, 2008, estimated at 2.32 billion U.S. dollars. Sales of these drugs in 2008 will total 71 billion U.S. dollars, accounting for 13.7% share of large-scale drug.

by: gaga

POST COMMENT

Trading Volatile Stock Market Investing in the Gold Market Affiliate Marketing Work Is Easier Than You Think Useful Tip For Marketing Executives Is To Combine Outlook Contact Lists Prominence of Email Marketing It Telemarketing: The Best Method To Generate Disaster Recovery Sales Leads How To Double Your Blog Subscribers With These 4 Best-kept Secret Blog Marketing Strategies Making Money In The Stock Market Doesn't Have To Be Rocket Science! The Spanish Fly Scam 1000 Calorie Challenge Scam-If you want to manage your overweight as soon as possible Where Next for the Crude Oil Futures Market? Where Next for the Forex Markets after more Quantitative Easing? Up or Down for the International Stock Markets?